Since 2009, PRM has provided oncology practices in the United States with the tools and services needed to deliver high quality, comprehensive patient care that promotes the appropriate utilization of healthcare resources. The PRM team is comprised of industry leaders dedicated to empowering physicians, and their practices, with value-based solutions that focus on standards of care, outcomes measurement, and financial sustainability. PRM provides business support and economic benefits that practices need to continue to offer high quality, comprehensive care. PRM’s value is demonstrated through our nationally recognized and innovative GPO contracts, strategic partnerships with the largest pharmaceutical distributors, and work with payer initiatives. These applied experiences enable us to deliver the optimal outcomes and value for your practice.
Providing value-based healthcare solutions, PRM aligns the demands of patients, providers and payers. We lead the industry in the development of quality practice, clinical and analytical solutions that increase efficiency in the provision of oncology care. PRM provides:
Proprietary, Industry Proven, Evidence-Based Pathways State of the Art Technology Platform Supporting Point-of-Service Decision MakingProven, Innovative Payer ModelsUnique Specialty Pharmacy Care Management Programs: Near Real-time Updates on Activities and Interactions With Your PatientPortfolio of Contracts with Best-in-Class Pricing PRM empowers our practices with healthcare solutions focused on better patient care, improved treatment outcomes and financial stability.
Chief Executive Officer
Executes developmental synergies across PRM business lines
Translates vision into strategy and execution
Former Vice President, Clinical Services and Chief Clinical Officer, Trinity Health
Career consultant engagements for pharmaceutical pipeline, new technologies, genomics, molecular imaging, and their impact on healthcare
“Gene’s vision and extensive clinical experience and health care executive leadership roles make him uniquely suited to lead the team at PRM.” Philip Stella, M.D.
PHILIP STELLA M.D.
Provides strategic guidance for PRM
Foster visionary payer initiatives
Oncologist, IHA Hematology Oncology Consultants
Medical Director, St. Joseph Mercy Hospital Cancer Care Center
History of leadership, vision, and dedication of time and talent to the advancement of cancer care in Michigan
Founding member and past president, Michigan Society Hematology and Oncology (MSHO)
Chair-Elect and serves on ASCO’s Government Relations Committee.
“Dr. Stella’s reputation as a clinician, patient advocate and oncology thought leader are remarkable.” – Doug Blayney, M.D.
DOUGLAS BLAYNEY, M.D.
Senior Medical Advisor
Provides guidance, oversight, and quality assurance in the development of the PRM oncology therapy management program
Assists in the direction and management of physician compliance protocols
Ann and John Doerr Medical Director, Stanford Cancer Institute
Professor, Internal Medicine (Oncology), Stanford University, Palo Alto, CA
Previously held the role of Medical Director, University of Michigan Comprehensive Cancer Center and Professor of Medicine, University of Michigan
President of the American Society of Clinical Oncology during the 2009-10 year
Serves on ASCO’s Quality of Cancer Care and Value Task Force committees
“Dr. Blayney’s experience as a community-based oncologist coupled with his leadership in the cancer center at the University of Michigan and his leadership of our country’s largest and most important professional society for oncologists has equipped him with a unique and variegated set of skills.” Philip Pizzo, MD, dean of Stanford’s medical school
AMY SEUNG, PHARM.D., BCOP
Senior Director, Clinical Pharmacy Initiatives
Develops evidence-based, clinical programs
Directs the development of care management and adherence monitoring for the oral oncolytic program
Extensively published and presented on the management of hematologic malignancies, symptom management, and oncology clinical decision support
NCCN Standard Chemotherapy Template Committee member
Previously served as the Clinical Pharmacy Specialist, Hematologic Malignancies and Oncology Clinical Decision Support at Johns Hopkins Hospital.
Vice President, Strategic and Business Development
Directs and manages PRM’s business development organization
Develops new business and strategic partnerships in the pharmaceutical, trade and genomics markets
Provides analysis of customer needs and ongoing customer discovery to inform product development
Former Vice President, Executive Director, Cancer Clinics of Excellence